(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...

UltraTech Cement, Dr Reddy’s Labs, Hindustan Petroleum, Mphasis, Zee, Indus Towers, Adani Green Energy, Adani Energy ...

Mankind Pharma shed 2.76% to Rs 2,560.05 after the company's consolidated net profit declined 16.2% to Rs 380.23 crore in Q3 FY25 as against Rs 453.76 crore posted in Q3 FY24.

The stock markets today will eye Q3 results of 81 domestic companies, Flash manufacturing PMI, IPOs, FII selling, and Budget ...

Dr Reddy’s Laboratories reports 2% increase in net profit, attributing growth to new acquisitions and product launches.

ADR shares of Tal Education Group ($TAL) surged 21.25% on Thursday as the smart learnings products maker reported better-than ...

IndiGo Q3 net profit is expected to see a sharp YoY fall due to costs associated with Aircraft on Ground (AoG) which have led to higher aircraft lease rentals, depreciation, and financing expenses.

IndiGo’s net profit is expected to fall 34% to ₹1,974 crore in Q3FY25 from ₹2,998.1 crore YoY. The company posted a net loss of ₹986.7 crore in the previous quarter.

Today, majors including DLF, Interglobe Aviation, Godrej Consumer Products, NIIT, DCB Bank, Bank of India, others are ...

The stock slumped 9 per cent to hit a low of Rs 994.05 over its previous close of Rs 1096.75. Market cap of the Tata Group ...

Torrent Pharma, IndiGo parent InterGlobe Aviation, Godrej Consumer Products, JSW Steel, and Bank of India are among few of the key firms that will report Q3 results today. Track updates here ...